Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04447469
Brief Title: Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

First Submitted : June 23, 2020
First Submitted that Met QC Criteria : June 24, 2020
First Posted : June 25, 2020

Last Update Submitted that Met QC Criteria : March 5, 2021
Last Update Posted : March 9, 2021